New Lymph Nodes Lighting Up on Your Scan — is it spread, or your immune system at work?

No — not always. A new or newly "lit up" lymph node on a PET-CT taken during immunotherapy is a genuine finding that needs following up, but it is not automatic proof of spread. Response frameworks built for checkpoint inhibitors treat a new node the same way they treat new growth elsewhere: unconfirmed until a repeat scan or further work-up settles the question.

Immune checkpoint inhibitors work by releasing a brake on your own T-cells so they can act against cancer — but that activated immune response doesn't stay confined to the tumour. It can also gather in lymph nodes that have nothing to do with your cancer, causing them to swell, take up more FDG tracer, and appear as a "new" finding on the report your oncologist reads.

This page explains general reporting terminology only. Response-assessment PET-CT for CION patients is coordinated through partner imaging centres, and only your treating oncologist can say what a specific new node on your own report means.

Patterns shown are general descriptions from oncology and radiology literature on checkpoint-inhibitor-related nodal reactions, indicative as of August 2026. No single row proves the answer either way — your oncologist reads them together, and a repeat scan or biopsy is often what actually settles it. This table is general education, not an interpretation of any individual scan.

1. 1

   Your report is compared against every prior scan

   The radiologist and oncologist check specifically whether the node is genuinely new, or was present earlier and simply measured or read differently this time.

2. 2

   The pattern is checked against your known cancer

   Nodes appearing exactly where your specific cancer is known to spread are read differently from nodes in an unrelated, symmetric distribution.

3. 3

   Your symptoms and other results are reviewed alongside the scan

   New pain, weight loss or organ-specific symptoms carry more weight than the node finding on its own.

4. 4

   A repeat scan or biopsy may follow before any change

   Many protocols recheck in four to eight weeks, or take a tissue sample from the node, rather than shifting your treatment plan off one report.

Checkpoint inhibitors work by removing a brake on T-cells, and activated T-cells don't only travel to the tumour — they also pass through your body's normal lymph node network. In a genuinely small number of patients, this activity is thought to trigger a granulomatous reaction: clusters of immune cells forming small nodules, most often described in the chest, that take up FDG tracer on a PET-CT and swell enough to be flagged as a lymph node of concern.

This is a real but under-documented pattern — case reports and imaging literature describe it more than large trials do, and it is reported far less often than pseudoprogression of the primary tumour itself. If your report mentions new nodes and this explanation hasn't been raised with you, it is a fair, specific question to bring to your oncologist rather than something to assume on your own.

• Nodes in the cancer's known drainage path — growth exactly where your specific cancer is expected to spread carries more weight than a node in an unrelated location.
• Uptake that keeps rising on serial scans — an FDG value climbing steadily over two or more scans points away from a settling immune reaction.
• New symptoms alongside the finding — pain, breathlessness or weight loss that is genuinely new adds weight to a spread reading.
• Growth at more than one new site — several new or enlarging areas together, rather than one isolated node, is read differently.
• Cancer cells on biopsy — a tissue sample remains the most direct way to settle the question when imaging alone stays inconclusive.

If you notice new or worsening symptoms, contact your oncology team promptly rather than waiting for a scheduled scan — this page explains general patterns, it does not triage individual symptoms.

• Tumour Markers on Immunotherapy: Why They Are Less Useful — why a rising marker alongside a new node still isn't read on its own.
• How Often Will You Be Scanned on Immunotherapy? — how the repeat-scan timeline behind this page's "confirm, don't panic" advice actually works.
• Understanding Your Response Assessment Report Line by Line — for the rest of the terminology on the same report.
• Immunotherapy at CION Cancer Clinics — the full picture of how CION supports patients through the immunotherapy journey.

This page explains general reasons new lymph nodes can appear on a scan during immunotherapy, for education only, and does not interpret any individual patient's report. Response-assessment PET-CT is coordinated at partner imaging centres. Bring your report to a consultation for a doctor's assessment of what it means for you.

Thousands of families have faced a scan report that says "new"

A report flagging new lymph nodes is one of the most frightening single words in oncology. Our oncologists take the time to explain what it can mean and what typically happens next.